Tekla Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $9.59M | Hold |
324,829
| – | – | 0.38% | 60 |
|
|
2023
Q1 | $7.48M | Buy |
324,829
+52,309
| +19% | +$1.21M | 0.28% | 66 |
|
|
2022
Q4 | $7.58M | Buy |
272,520
+50,100
| +23% | +$1.39M | 0.29% | 65 |
|
|
2022
Q3 | $6.83M | Hold |
222,420
| – | – | 0.28% | 67 |
|
|
2022
Q2 | $6.55M | Hold |
222,420
| – | – | 0.26% | 75 |
|
|
2022
Q1 | $7.16M | Hold |
222,420
| – | – | 0.25% | 77 |
|
|
2021
Q4 | $9.92M | Hold |
222,420
| – | – | 0.32% | 68 |
|
|
2021
Q3 | $11.2M | Buy |
222,420
+72,334
| +48% | +$3.65M | 0.36% | 68 |
|
|
2021
Q2 | $11.8M | Hold |
150,086
| – | – | 0.38% | 70 |
|
|
2021
Q1 | $8.57M | Buy |
150,086
+77,753
| +107% | +$4.44M | 0.29% | 89 |
|
|
2020
Q4 | $6.06M | Buy |
+72,333
| New | +$6.06M | 0.21% | 108 |
|
|
2019
Q2 | – | Sell |
-19,372
| Closed | -$450K | – | 200 |
|
|
2019
Q1 | $450K | Buy |
+19,372
| New | +$450K | 0.02% | 182 |
|